Van Lint, Sandra
Van Parys, Alexander
Van Den Eeckhout, Bram
Vandamme, Niels
Plaisance, Stephane
Verhee, Annick
Catteeuw, Dominiek
Rogge, Elke
De Geest, Jennifer
Vanderroost, Nele
Roels, Jana
Saeys, Yvan
Uzé, Gilles
Kley, Niko
Cauwels, Anje
Tavernier, Jan
Funding for this research was provided by:
Bijzonder Onderzoeksfonds UGent
Fonds Wetenschappelijk Onderzoek (132118N)
Methusalem
European Research Council (CYRE, 340941)
Article History
Received: 13 August 2023
Accepted: 22 November 2023
First Online: 29 November 2023
Declarations
:
: NK and JT are affiliated with Orionis Biosciences NV and hold equity interests. NK and JT have no additional financial interests. The following patent applications are related to the work presented in this paper: WO/2017/134305, Bispecific signaling agents and uses thereof. Applicants: VIB-Ghent University and Orionis Biosciences N.V. Inventors: N.K., J.T., S.V.L., A.C. The remaining authors declare no competing interests.